Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 3681731, 8 pages
http://dx.doi.org/10.1155/2016/3681731
Clinical Study

Pathological Predictors of Shunt Stenosis and Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt

1Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, The 9th Affiliated Hospital of Peking University, Beijing 100038, China
2Department of Plastic Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China
3Department of Internal Medicine, Section of Hematology-Oncology, Section of Gastroenterology, Stephenson Cancer Center, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA

Received 14 July 2016; Revised 22 August 2016; Accepted 31 August 2016

Academic Editor: Xingshun Qi

Copyright © 2016 Fuliang He et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F.-L. He, L. Wang, Z.-D. Yue, H.-W. Zhao, and F.-Q. Liu, “Parallel transjugular intrahepatic portosystemic shunt for controlling portal hypertension complications in cirrhotic patients,” World Journal of Gastroenterology, vol. 20, no. 33, pp. 11835–11839, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. Z. Ling, X. Liu, Y. Cheng et al., “Decreased diversity of the oral microbiota of patients with hepatitis B virus-induced chronic liver disease: a pilot project,” Scientific Reports, vol. 5, Article ID 17098, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Rössle, “Root cause analysis: can it improve outcome after transjugular intrahepatic portosystemic shunt creation?” Journal of Vascular and Interventional Radiology, vol. 26, no. 10, pp. 1453–1454, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. B. C. Perry and S. W. Kwan, “Portosystemic shunts: stable utilization and improved outcomes, two decades after the transjugular intrahepatic portosystemic shunt,” Journal of the American College of Radiology, vol. 12, no. 12, pp. 1427–1433, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Yao, L. Zuo, G. An et al., “Risk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma and portal hypertension,” Journal of Gastrointestinal and Liver Diseases, vol. 24, no. 3, pp. 301–307, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Ahluwalia, J. B. Wade, F. G. Moeller et al., “The etiology of cirrhosis is a strong determinant of brain reserve: a multimodal magnetic resonance imaging study,” Liver Transplantation, vol. 21, no. 9, pp. 1123–1132, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Siramolpiwat, “Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications,” World Journal of Gastroenterology, vol. 20, no. 45, pp. 16996–17010, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. J. G. Abraldes and P. Tandon, “Therapies: drugs, scopes and transjugular intrahepatic portosystemic shunt—when and how?” Digestive Diseases, vol. 33, no. 4, pp. 524–533, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. J. S. Bajaj, “Diagnosing minimal hepatic encephalopathy: from the ivory tower to the real world,” Gastroenterology, vol. 149, no. 6, pp. 1330–1333, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. P. V. Suhocki, M. P. Lungren, B. Kapoor, and C. Y. Kim, “Transjugular intrahepatic portosystemic shunt complications: prevention and management,” Seminars in Interventional Radiology, vol. 32, no. 2, pp. 123–132, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. S. S. Sabri, N. Abi-Jaoudeh, W. Swee et al., “Short-term rebleeding rates for isolated gastric varices managed by transjugular intrahepatic portosystemic shunt versus balloon-occluded retrograde transvenous obliteration,” Journal of Vascular and Interventional Radiology, vol. 25, no. 3, pp. 355–361, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. B. I. Engstrom, J. J. Horvath, P. V. Suhocki et al., “Covered transjugular intrahepatic portosystemic shunts: accuracy of ultrasound in detecting shunt malfunction,” American Journal of Roentgenology, vol. 200, no. 4, pp. 904–908, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. J. M. Perarnau, A. Le Gouge, C. Nicolas et al., “Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial,” Journal of Hepatology, vol. 60, no. 5, pp. 962–968, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Ataseven, I. H. Bahcecioglu, N. Kuzu et al., “The levels of ghrelin, leptin, TNF-α, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection,” Mediators of Inflammation, vol. 2006, Article ID 78380, 6 pages, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. J.-T. Kao, C.-J. Yu, C.-L. Feng, S.-M. Tsai, Y.-L. Chen, and Y.-Y. Wu, “IL-6 significantly correlates with p-STAT3 expression and presents high variceal bleeding with mortality in cirrhotic patients: a cross-sectional study,” Journal of Microbiology, Immunology and Infection, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. Z.-Y. Xia, H. Yang, H.-Q. Qu, W.-D. Cheng, and L.-X. Wang, “Impact of carotid artery stenting on plasma interleukin-6, tumor necrosis factor-α and C-reactive protein,” International Angiology, vol. 31, no. 1, pp. 28–32, 2012. View at Google Scholar · View at Scopus
  17. G. Niccoli, “Inflammation: a key mechanism of adverse reactions to coronary stent and a target for future therapies,” Current Vascular Pharmacology, vol. 11, no. 4, pp. 377–378, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Merola, N. Chaudhary, M. Qian et al., “Hyponatremia: a risk factor for early overt encephalopathy after transjugular intrahepatic portosystemic shunt creation,” Journal of Clinical Medicine, vol. 3, no. 2, pp. 359–372, 2014. View at Publisher · View at Google Scholar
  19. P. Peter, Z. Andrej, S. P. Katarina, G. Manca, and S. Pavel, “Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with recurrent variceal hemorrhage,” Gastroenterology Research and Practice, vol. 2013, Article ID 398172, 5 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Bai, X. Qi, Z. Yang et al., “Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review,” Journal of Gastroenterology and Hepatology, vol. 26, no. 6, pp. 943–951, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. O. Riggio, S. Angeloni, F. M. Salvatori et al., “Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts,” The American Journal of Gastroenterology, vol. 103, no. 11, pp. 2738–2746, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. J. Haskal and J. Radhakrishnan, “Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy,” Journal of Vascular and Interventional Radiology, vol. 19, no. 4, pp. 516–520, 2008. View at Publisher · View at Google Scholar · View at Scopus